[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].

Debruyne, F; Koch, G; Boyle, P; Da Silva, FC; Gillenwater, JG; Hamdy, FC; Perrin, P; Teillac, P; Vela-Navarrete, R; Raynaud, JP

Abstract:

OBJECTIVE: While the lipidosterolic extract (LSESr) of Serenoa repens--Permixon--has been shown to have an equivalent efficacy to finasteride in patients with benign prostatic hyperplasia (BPH), to date, there has been no valid comparison of phytotherapy with alpha-blockers. The aim of this study was to assess the equivalent efficacy of Permixon and tamsulosin. METHODS: Eight hundred and eleven men with symptomatic BPH (international prostdate symptom score, I-PSS > or = 10) were recruite...

Expand abstract

Publication status:

Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Debruyne, F., Koch, G., Boyle, P., Da Silva, F. C., Gillenwater, J. G., Hamdy, F. C., Perrin, P., Teillac, P., Vela-Navarrete, R., & Raynaud, J. P. (2002). [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]. Progres En Urologie : Journal De l'Association Francaise d'Urologie Et De La Societe Francaise d'Urologie, 12(3), 384–392.

MLA Style

Debruyne, F., et al. “[Comparison of a Phytotherapeutic Agent (Permixon) with an Alpha-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: a 1-Year Randomized International Study].” Progres En Urologie : Journal De l'Association Francaise d'Urologie Et De La Societe Francaise d'Urologie, vol. 12, no. 3, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2002, pp. 384–92.

Chicago Style

Debruyne, F, G Koch, P Boyle, FC Da Silva, JG Gillenwater, FC Hamdy, P Perrin, P Teillac, R Vela-Navarrete, and JP Raynaud. 2002. “[Comparison of a Phytotherapeutic Agent (Permixon) with an Alpha-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: a 1-Year Randomized International Study].” Progres En Urologie : Journal De l'Association Francaise d'Urologie Et De La Societe Francaise d'Urologie 12 (3): 384–92.
Tweet
Print

Authors

Debruyne, F More by this author

Koch, G More by this author

Boyle, P More by this author

Da Silva, FC More by this author

Gillenwater, JG More by this author

Expand authors...

Bibliographic Details

Journal:: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
Volume:: 12
Issue:: 3
Pages:: 384-392
Publication date:: 2002-06-05
ISSN:: 1166-7087
URN:: uuid:c5440ad5-88a6-47e6-83fd-7323ac176a0a
Source identifiers:: 120709
Local pid:: pubs:120709

Item Description

Language:: French
Keywords:: Phytotherapy

Male

Adrenergic alpha-Antagonists

Prostate-Specific Antigen

Severity of Illness Index

Humans

Serenoa

Groupe d'étude PERMAL

Plant Extracts

Androgen Antagonists

Aged

Prostatic Hyperplasia

Middle Aged

Aged, 80 and over

Double-Blind Method

Sulfonamides

Sensitivity and Specificity

Terms of use

License:: Terms and Conditions of Use for Oxford University Research Archive

Views & Downloads

Metrics

If you are the owner of this record, you can report an update to it here: Report update to this record